About this Journal Submit a Manuscript Table of Contents
Oxidative Medicine and Cellular Longevity
Volume 2012 (2012), Article ID 489690, 6 pages
Research Article

Cholesterol-Lowering Effect of Allicin on Hypercholesterolemic ICR Mice

1College of Biological and Environmental Engineering, Zhejiang Shuren University, Hangzhou 310015, China
2Institute of Bioengineering, Zhejiang Academy of Medical Science, Hangzhou 310013, China
3School of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou 310023, China
4Department of Biology, Shaoxing No.1 High School, Shengli West Road 1199, Yuecheng District, Shaoxing 312000, China
5Cardiovascular Department, Integrated Chinese and Western Medicine Hospital, Hangzhou Shangcheng District, Hangzhou 310008, China

Received 13 March 2012; Accepted 12 June 2012

Academic Editor: Michal Wozniak

Copyright © 2012 Yin Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Steinberg, S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum, “Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity,” The New England Journal of Medicine, vol. 320, no. 14, pp. 915–924, 1989. View at Scopus
  2. H. Esterbauer, J. Gebicki, H. Puhl, and G. Jurgens, “The role of lipid peroxidation and antioxidants in oxidative modification of LDL,” Free Radical Biology and Medicine, vol. 13, no. 4, pp. 341–390, 1992. View at Publisher · View at Google Scholar · View at Scopus
  3. K. S. Bramlett, K. A. Houck, K. M. Borchert et al., “A natural product ligand of the oxysterol receptor, liver X receptor,” Journal of Pharmacology and Experimental Therapeutics, vol. 307, no. 1, pp. 291–296, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. L. K. Han, Y. N. Zheng, B. J. Xu, H. Okuda, and Y. Kimura, “Saponins from Platycodi radix ameliorate high fat diet-induced obesity in mice,” Journal of Nutrition, vol. 132, no. 8, pp. 2241–2245, 2002. View at Scopus
  5. K. C. Agarwal, “Therapeutic actions of garlic constituents,” Medicinal Research Reviews, vol. 16, pp. 111–124, 1996.
  6. S. Phelps and W. S. Harris, “Garlic supplementation and lipoprotein oxidation susceptibility,” Lipids, vol. 28, no. 5, pp. 475–477, 1993. View at Scopus
  7. C. Legnani, M. Frascaro, G. Guazzaloca, S. Ludovici, G. Cesarano, and S. Coccheri, “Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects,” Arzneimittel-Forschung/Drug Research, vol. 43, no. 2, pp. 119–122, 1993. View at Scopus
  8. E. S. Lee, M. Steiner, and R. Lin, “Thioallyl compounds: potent inhibitors of cell proliferation,” Biochimica et Biophysica Acta, vol. 1221, no. 1, pp. 73–77, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. A. N. Orekhov, V. V. Tertov, I. A. Sobenin, and E. M. Pivovarova, “Direct anti-atherosclerosis-related effects of garlic,” Annals of Medicine, vol. 27, no. 1, pp. 63–65, 1995. View at Scopus
  10. K. K. Al-Qattan, M. A. Alnaqeeb, and M. Ali, “The antihypertensive effect of garlic (Allium sativum) in the rat two- kidney-one-clip Goldblatt model,” Journal of Ethnopharmacology, vol. 66, no. 2, pp. 217–222, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Bolton, G. Null, and W. M. Troetel, “The medical uses of garlic—fact and fiction,” American Pharmacy, vol. NS22, no. 8, pp. 40–43, 1982. View at Scopus
  12. H. D. Reuter, H. P. Koch, and L. D. Lawson, “Therapeutic effects and applications of garlic and its preparations,” in The Science and Therapeutic Application of Allium Sativum and Related Species, H. P. Koch and L. Lawson LDGarlic, Eds., Williams and Wilkins, Baltimore, Md, USA, 1996.
  13. D. Abramovitz, S. Gavri, D. Harats et al., “Allicin-induced decrease in formation of fatty streaks (atherosclerosis) in mice fed a cholesterol-rich diet,” Coronary Artery Disease, vol. 10, no. 7, pp. 515–519, 1999. View at Scopus
  14. S. K. Banerjee and S. K. Maulik, “Effect of garlic on cardiovascular disorders: a review,” Nutrition Journal, vol. 1, article 1, pp. 1–14, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. L. D. Brace, “Cardiovascular benefits of garlic (Allium sativum L.),” Journal of Cardiovascular Nursing, vol. 16, no. 4, pp. 33–49, 2002. View at Scopus
  16. M. J. Kwon, Y. S. Song, M. S. Choi, S. J. Park, K. S. Jeong, and Y. O. Song, “Cholesteryl ester transfer protein activity and atherogenic parameters in rabbits supplemented with cholesterol and garlic powder,” Life Sciences, vol. 72, no. 26, pp. 2953–2964, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. S. M. S. Espirito Santo, B. J. M. van Vlijmen, R. Buytenhek et al., “Well-characterized garlic-derived materials are not hypolipidemic in APOE*3-Leiden transgenic mice,” Journal of Nutrition, vol. 134, no. 6, pp. 1500–1503, 2004. View at Scopus
  18. G. F. Watts, B. Lewis, J. N. H. Brunt et al., “Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS),” The Lancet, vol. 339, no. 8793, pp. 563–569, 1992. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Paigen, A. Morrow, and C. Brandon, “Variation in susceptibility to atherosclerosis among inbred strains of mice,” Atherosclerosis, vol. 57, no. 1, pp. 65–73, 1985. View at Scopus
  20. S. Eilat, Y. Oestraicher, A. Rabinkov et al., “Alteration of lipid profile in hyperlipidemic rabbits by allicin, an active constituent of garlic,” Coronary Artery Disease, vol. 6, no. 12, pp. 985–990, 1995. View at Scopus
  21. A. Gonen, D. Harats, A. Rabinkov et al., “The antiatherogenic effect of allicin: possible mode of action,” Pathobiology, vol. 72, no. 6, pp. 325–334, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Coppi, M. Cabinian, D. Mirelman, and P. Sinnis, “Antimalarial activity of allicin, a biologically active compound from garlic cloves,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 5, pp. 1731–1737, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. J. George, A. Afek, B. Gilburd et al., “Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis,” Atherosclerosis, vol. 138, no. 1, pp. 147–152, 1998. View at Publisher · View at Google Scholar · View at Scopus